MedTech & Cardiology
Boston Scientific procedure outperforms drugs for heart rhythm disorder
What’s happening
A clinical trial showed a minimally invasive procedure using a Boston Scientific device may be more effective than medication for atrial fibrillation.
What’s changing / Business impact
-
Shift from: drug-based → procedure-based treatment.
-
Expands role of: medical devices and interventional care.
Why this matters
Treatment pathways are evolving beyond pharmaceuticals.
This shows:
-
Devices can compete directly with drugs.
-
Care models are becoming multi-modal.
-
Innovation is happening across multiple layers of care.